Prostate Cancer - Results from #120

REVIEW UroToday

The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer - Beyond the Abstract November 20, 2023

Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer with Abiraterone or Enzalutamide - Beyond the Abstract November 13, 2023

Perspectives on Prostate Cancer: Advances and Pending Challenges for a Multidisciplinary Oncological Approach in South America - Beyond the Abstract November 2, 2023

Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE) - Beyond the Abstract October 31, 2023

Clinical and Functional Analyses of an African-Ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer - Beyond the Abstract October 30, 2023

Safety and Efficiency of Repeat Salvage Lymph Node Dissection for Recurrence of Prostate Cancer Using PSMA-Radioguided Surgery (RGS) after Prior Salvage Lymph Node Dissection with or without Initial RGS Support - Beyond the Abstract October 30, 2023

Revolutionizing Prostate Cancer Care: AI-Based PTEN Assessment of Digital Pathology Images as a Game-Changer in Predicting Metastasis - Beyond the Abstract October 18, 2023

Development and Validation of a New BAG-1L–Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer – Beyond the Abstract October 11, 2023

The Akt/mTOR and MNK/eIF4E Pathways Rewire the Prostate Cancer Translatome to Secrete HGF, SPP1 and BGN and Recruit Suppressive Myeloid Cells - Beyond the Abstract October 3, 2023

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis - Beyond the Abstract October 3, 2023

Influence of ADT on B7-H3 Expression During CRPC Progression from Hormone-Naïve Prostate Cancer - Beyond the Abstract September 28, 2023

Testosterone Therapy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations - Beyond the Abstract September 26, 2023

DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy - Beyond the Abstract September 25, 2023

Daily Physical Activity Monitoring in Older Adults with Metastatic Prostate Cancer on Active Treatment: Feasibility and Associations with Toxicity - Beyond the Abstract September 20, 2023

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial - Beyond the Abstract September 18, 2023

A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer - Beyond the Abstract September 14, 2023

Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools - Beyond the Abstract September 13, 2023

Location Matters: Could Nucleo-Cytoplasmic ErbB3 Shift the Balance from Treatment Resistance to Treatment Efficacy in Castration-Resistant Prostate Cancer? - Beyond the Abstract September 13, 2023

"TREXIT 2020": Why the Time to Abandon Transrectal Prostate Biopsy Starts Now - Beyond the Abstract September 11, 2023

Assessing the Feasibility of Utilizing Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost with External Beam Radiation Therapy - Beyond the Abstract September 5, 2023

Page 7 of 57